Literature DB >> 31421170

Molecular recognition of 3+1 hybrid human telomeric G-quadruplex DNA d-[AGGG(TTAGGG)3] by anticancer drugs epirubicin and adriamycin leads to thermal stabilization.

Shailja Raje1, Ritu Barthwal2.   

Abstract

Recent reports suggest influence of anti-cancer anthracyclines on telomere dysfunction and their possible interaction with G-quadruplex (G4) DNA as an alternate pathway to apoptosis. We have investigated interaction of epirubicin and adriamycin with G4 DNA [d-AGGG(TTAGGG)3] comprising human telomeric DNA sequence by surface plasmon resonance, absorption, fluorescence, circular dichroism and thermal denaturation. Epirubicin and adriamycin bind with affinity, Kb, = 2.5×105 and 5.2×105M-1, respectively in monomeric form leading to decrease in absorbance, fluorescence quenching and ellipticity changes without any significant shift in absorption emission maxima with corresponding induced thermal stabilization by 13.0 and 11.6°C in K+ rich solution. Na+ ions did not induce any thermal stabilization. Molecular docking confirmed external binding at grooves and loops of G4 DNA involving 4OCH3 of ring D, 9COCH2OH of ring A, 4'OH/H and 3'NH3+ of daunosamine sugar. Thermal stabilization induced by specific interactions is likely to hamper telomere association with telomerase enzyme and contribute to drug-induced apoptosis in cancer cell lines besides causing damage to duplex DNA. The findings pave the way for drug designing in view of immense possibilities of altering substituent groups on anthracyclines for enhancement of efficacy, reduced cell toxicity as well as specificity towards G-quadruplex DNA.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epirubicin and adriamycin; Human telomeric DNA; Molecular docking; Spectroscopy techniques; Surface plasmon resonance; Thermal stabilization

Mesh:

Substances:

Year:  2019        PMID: 31421170     DOI: 10.1016/j.ijbiomac.2019.08.109

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  2 in total

1.  Astragaloside IV inhibits adriamycin-induced cardiac ferroptosis by enhancing Nrf2 signaling.

Authors:  Li-Fei Luo; Peng Guan; Lu-Yun Qin; Jian-Xin Wang; Na Wang; En-Sheng Ji
Journal:  Mol Cell Biochem       Date:  2021-03-03       Impact factor: 3.396

2.  The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma.

Authors:  Min Pan; William C Wright; Richard H Chapple; Asif Zubair; Manbir Sandhu; Jake E Batchelder; Brandt C Huddle; Jonathan Low; Kaley B Blankenship; Yingzhe Wang; Brittney Gordon; Payton Archer; Samuel W Brady; Sivaraman Natarajan; Matthew J Posgai; John Schuetz; Darcie Miller; Ravi Kalathur; Siquan Chen; Jon Patrick Connelly; M Madan Babu; Michael A Dyer; Shondra M Pruett-Miller; Burgess B Freeman; Taosheng Chen; Lucy A Godley; Scott C Blanchard; Elizabeth Stewart; John Easton; Paul Geeleher
Journal:  Nat Commun       Date:  2021-11-09       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.